Emetant-IV Injection
By Emetant
Rx
1 Injection in a Vial

Composition
Fosaprepitant(150mg)

Manufacturer - Adley Formulations
Adley Formulation, SCO- 42, Sector 12, Panchkula-134112, Haryana, India

Expires on or after
July, 2025

liver
Emetant-IV Injection should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of Emetant-IV Injection in these patients. It is important to consult a healthcare professional before using this medication. However, no dose adjustment is typically required for individuals with moderate to severe liver disease. If you have any concerns about how your liver condition may affect the use of Emetant-IV Injection, it's best to seek advice from your healthcare provider.

kidney
Emetant-IV Injection can be used safely in patients with kidney disease. It is not necessary to adjust the dose of Emetant-IV Injection for patients with kidney issues.

alcohol
It is unsafe to consume alcohol with Emetant-IV Injection.

driving
Emetant-IV Injection might reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Emetant-IV Injection is generally safe to use during pregnancy. Animal studies found minimal harm to the baby, but human studies are limited.

breastfeeding
Emetant-IV Injection may not be safe to use during breastfeeding as it may pass into breastmilk and harm the baby. Limited human data is available on this.
Habit Forming | No |
Chemical Class | Phenylmorpholine Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | NK1 Antagonists |
₹2695
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024